Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Hearing 2 Oct

You wrote: .."Mr Hogg spoke up over the phone representing PTSC in support, pointing out that TPL had been delaying and obstructing the part of the joint plan calling for approving a second licensing entity besides Alliacense.".

I assume you are speaking specifically of Objections to the Joint Plan of Unsecured Creditors, which Mr Hoge "represent(ed) PTSC's support" for ?

Please share your impressions and observations of PTSC's position with regards the Moore Monetization Plan.

Thanks

Share
New Message
Please login to post a reply